The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 14% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 28%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (15 analysts) rates it buy, with a mean price target of $111.
Shell PLC
SHEL · NYSE (ADR) · Market cap $263.3B · 84,000 employees
Shell plc operates as an energy and petrochemical company in Europe, Asia, Oceania, Africa, the United States, and other parts of the Americas.
Not yet scoredPrice as of 18 Nov 2026Daily close, not a live quote
Screened 2026-11-18 · the tape above runs as of 08:05 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price94.34 at the 18 Nov 2026 close
- Our value readOvervalued vs our fair value, as of 18 Nov 2026
- Our regime readDistribution, as of 15 Nov 2026
- Ethical screenNot yet scored
- OptionsOpen interest leans heavily to calls (put/call 0.28)
- Last reviewed18 Nov 2026 (2 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: 70.20 to 89.31 , base estimate 77.66 (screen dated 2026-11-18).
- Trend Distribution
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 0.28, read 2026-11-19
- Ethical screen not yet scored
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its distribution label.
Shell PLC holds its Distribution at $94.34. Consolidating, no directional conviction, held for 353 days.
| Phase | Distribution · caution |
| Quantitative state | Consolidating, no directional conviction, held for 353 days |
| Price at the screen | $94.34 |
| Valuation | 13.23 trailing · 9.92 forward price to earnings |
| Values screen | Not scored · score 50.0 |
| Beta | -0.24 |
Five Screens: SHEL's Results
This security has not been fully scored against the values screen yet.
| Test | Figure | Limit | Status |
|---|---|---|---|
| Business activity | Permissible | Permissible core business | Pass |
| Revenue purity | 0.78% | Below 5% | Pass |
Definitions, sources and threshold rules: ticker values-screen methodology.
The Ethical ReadThe Read, in Plain English
Shell clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Read as at 2026-11-19. It updates when the underlying figures move, and past reads are kept below.
What the Numbers Say It Is WorthThe Fair Value Range
Our analysis reads Overvalued vs our fair value, as of 18 Nov 2026: it trades above our 77.66 fair value estimate, narrow competitive moat, 0.70% revenue growth.
Model construction and limits: fair-value methodology.
Fair value range in , drawn from the 2026-11-18 screen. The gold marker is the market price at the same screen. The price runs 21.5% above the base estimate.
Third-party analyst targets: 14 covering, consensus Buy. The average target sits +6% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & ProjectionsWhere our models see it going: fair-value estimate 77.66 , with a range of 70.20 to 89.31 , dated to the 2026-11-18 screen.
How our estimate and third-party targets differ.
The Business, in Plain Words| Forward P/E | 9.9xexpensive even after accounting for its growth |
| Trailing P/E | 13.2xreasonably valued |
| EPS, forward | 9.53 |
| Revenue growth | +0.7%slow but positive growth |
| Profit margin | 7.0%thin but positive margins |
| Return on equity | 10.7%a modest return on shareholder capital |
| Dividend yield | 3.31% |
| Debt to equity | 0.43minimal debt: a conservative balance sheet |
| Current ratio | 1.28adequate liquidity, worth monitoring |
| Beta | -0.24barely tracks the market's swings |
| Short interest, float | 0.01% |
| 52-week range | 65.38 - 94.90 |
| Moat | NARROW |
| Market cap | $263.3B |
| Employees | 84,000 |
SHEL-specific watchpoints · The things to watch: its business and earnings are exposed to United Kingdom and to currency swings.
Metric definitions and interpretation rules: ticker-page methodology.
Every Entry, As Written
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 6.7% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 14% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 28%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (15 analysts) rates it buy, with a mean price target of $111.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 0.6% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 27% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 28%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (15 analysts) rates it buy, with a mean price target of $109.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 27% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 28%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (15 analysts) rates it buy, with a mean price target of $106.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 3.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 23% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 28%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (15 analysts) rates it buy, with a mean price target of $105.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 6.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 10% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 28%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (15 analysts) rates it buy, with a mean price target of $105.
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 10.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 10% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 28%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (15 analysts) rates it buy, with a mean price target of $104.
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 10% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 28%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (15 analysts) rates it buy, with a mean price target of $98.
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical pass with moderate score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 10% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 28%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (14 analysts) rates it buy, with a mean price target of $101. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical pass with moderate score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 10% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 28%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (14 analysts) rates it buy, with a mean price target of $101. It reported earnings in this window, a natural checkpoint for the thesis.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-04 | Taraporevala (Cyrus) | · | · | ||
| 2026-03-04 | Hughes (Catherine J) | · | · | ||
| 2026-03-04 | Lute (Jane H) | · | · | ||
| 2026-03-04 | Godbehere (Ann Frances) | · | · | ||
| 2025-12-31 | Godbehere (Ann Frances) | · | · | ||
| 2025-12-31 | Hughes (Catherine J) | · | · | ||
| 2025-12-31 | Lute (Jane H) | · | · | ||
| 2025-12-31 | Taraporevala (Cyrus) | · | · |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $103.99 | -9.3% | $0.78 | $915 | -8.5% |
| 2 months | $93.79 | +0.6% | $0.78 | $1,014 | +1.4% |
| 3 months | $92.91 | +1.5% | $0.78 | $1,024 | +2.4% |
| 6 months | $84.29 | +11.9% | $2.34 | $1,147 | +14.7% |
| 1 year | $72.72 | +29.7% | $3.09 | $1,340 | +34.0% |
| 2 years | $61.48 | +53.4% | $5.95 | $1,631 | +63.1% |
| 3 years | $58.65 | +60.9% | $8.70 | $1,757 | +75.7% |
| 5 years | $36.00 | +162.1% | $12.68 | $2,973 | +197.3% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever SHEL does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.